Hantech Bio-Technology Co., Ltd. (TPEX:1294)
Taiwan · Delayed Price · Currency is TWD 78.00
-0.20 (-0.26%)
May 8, 2026, 1:30 PM CST
Hantech Bio-Technology Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 139.05 | 155.67 | 148.12 | 47.47 | 32.56 |
Depreciation & Amortization | 38.17 | 30.35 | 19.44 | 18.86 | 18.24 |
Other Amortization | - | 1.72 | 1.5 | 0.47 | 0.46 |
Loss (Gain) From Sale of Assets | - | 0.35 | 0.11 | 0.55 | 0 |
Asset Writedown & Restructuring Costs | 3.27 | - | - | - | - |
Loss (Gain) From Sale of Investments | 0.74 | - | - | - | - |
Stock-Based Compensation | 0.11 | 1.03 | 0.05 | 0.17 | 4.22 |
Provision & Write-off of Bad Debts | 0.57 | -0.03 | -0.56 | 0.61 | -1.05 |
Other Operating Activities | -4.77 | -7.07 | 20.99 | 7.75 | -14.59 |
Change in Accounts Receivable | -53.94 | 7.94 | -37.82 | -25.73 | 6.81 |
Change in Inventory | -48.32 | 13.76 | -50.08 | -9.72 | 1.46 |
Change in Accounts Payable | 69.36 | -52.85 | 65.47 | 20.05 | -2.73 |
Change in Other Net Operating Assets | 16.39 | -0.13 | 24.68 | 2.69 | -0.98 |
Operating Cash Flow | 160.63 | 150.75 | 191.91 | 63.18 | 44.39 |
Operating Cash Flow Growth | 6.55% | -21.44% | 203.76% | 42.33% | -59.95% |
Capital Expenditures | -15.45 | -24.63 | -293.94 | -82.88 | -79.26 |
Sale of Property, Plant & Equipment | - | - | 1.83 | 0.11 | - |
Sale (Purchase) of Intangibles | -1.27 | -0.76 | -3.28 | -0.74 | -1.06 |
Investment in Securities | -90.72 | - | -1.2 | - | - |
Other Investing Activities | 0.03 | 0.01 | 0.96 | -0.57 | 0.56 |
Investing Cash Flow | -107.4 | -25.38 | -295.63 | -84.07 | -79.76 |
Short-Term Debt Issued | 5 | 5 | 9 | 10 | 4 |
Long-Term Debt Issued | - | 42.21 | 269.32 | 26.34 | 55.53 |
Total Debt Issued | 5 | 47.21 | 278.32 | 36.34 | 59.53 |
Short-Term Debt Repaid | -5 | -5 | -10 | -13 | - |
Long-Term Debt Repaid | -58.5 | -215.44 | -57.72 | -58.45 | -14.24 |
Total Debt Repaid | -63.5 | -220.44 | -67.72 | -71.45 | -14.24 |
Net Debt Issued (Repaid) | -58.5 | -173.23 | 210.6 | -35.11 | 45.29 |
Issuance of Common Stock | 29.08 | 282.4 | 2.07 | 44.63 | 3.17 |
Repurchase of Common Stock | -69.37 | - | - | - | - |
Common Dividends Paid | -87.43 | -19.42 | -16.84 | - | -8.06 |
Other Financing Activities | -0.06 | - | - | - | - |
Financing Cash Flow | -186.29 | 89.75 | 195.83 | 9.52 | 40.4 |
Foreign Exchange Rate Adjustments | 0.03 | 0.21 | -0.05 | 0 | -0.4 |
Net Cash Flow | -133.03 | 215.33 | 92.05 | -11.37 | 4.63 |
Free Cash Flow | 145.19 | 126.13 | -102.03 | -19.7 | -34.87 |
Free Cash Flow Growth | 15.11% | - | - | - | - |
Free Cash Flow Margin | 18.65% | 16.85% | -16.32% | -6.51% | -14.51% |
Free Cash Flow Per Share | 4.74 | 4.31 | -3.60 | -0.76 | -1.44 |
Cash Interest Paid | 1.25 | 3.44 | 1.42 | 0.31 | 0.83 |
Cash Income Tax Paid | 40.04 | 47.43 | 15.49 | 5.13 | 21.14 |
Levered Free Cash Flow | 91.4 | 88.6 | -139.37 | -32.65 | -42.65 |
Unlevered Free Cash Flow | 93.26 | 91.96 | -138.05 | -31.74 | -41.68 |
Change in Working Capital | -16.51 | -31.28 | 2.25 | -12.7 | 4.55 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.